Japanese Pharmaceuticals & Biotech Most Popular Stocks

SymBio Pharmaceuticals

Market Cap: JP¥4.7b

Engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally.

Ribomic

Market Cap: JP¥4.7b

Engages in the discovery and development of pharmaceutical compounds using RNA aptamers in Japan and Europe.

Linical

Market Cap: JP¥4.7b

A global contract research organization, provides full spectrum of drug development services to pharmaceutical companies worldwide.

Kohjin Bio

Market Cap: JP¥4.3b

Manufactures and sells animal blood, serum, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.

Transgenic Group

Market Cap: JP¥4.2b

Develops, distributes, and licenses genetically modified animals and antibodies in Japan.

MedRx

Market Cap: JP¥4.0b

A pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan.

Kringle Pharma

Market Cap: JP¥3.7b

Engages in research and develops therapeutic agents for the treatment of intractable diseases in Japan.

Human Metabolome Technologies

Market Cap: JP¥3.6b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

Modalis Therapeutics

Market Cap: JP¥3.4b

Engages in the research and development of therapeutics to treat patients with serious genetic disorders.

Veritas In Silico

Market Cap: JP¥2.9b

Engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA.

atect

Market Cap: JP¥2.9b

Engages in the sanitation inspection equipment, powder injection molding (PIM), and semiconductor material businesses in Japan, South Korea, Taiwan, and internationally.

Perseus Proteomics

Market Cap: JP¥2.7b

A drug discovery biotech venture company, develops and sells antibody-based pharmaceuticals and research reagents for cancer and other diseases in Japan.

FunPep

Market Cap: JP¥2.5b

Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices in Japan and internationally.

Delta-Fly Pharma

Market Cap: JP¥1.5b

Develops anticancer drugs.

PhoenixBio

Market Cap: JP¥1.4b

Provides contract testing services for medical product development in Japan, the United States, and internationally.